Elevance Health (ELV) Stock Price, News & Analysis

Company Overview

Elevance Health, Inc. (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc. to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products. The company also delivers administrative services and clinical care-management solutions, operates pharmacy benefit services, and provides digital tools meant to support care coordination, population health management and member engagement. Through its operating units, Elevance contracts with provider networks and develops programs aimed at improving quality of care and managing costs.

Elevance primarily serves customers across the United States, working with employers, state and federal health programs, providers and other stakeholders in the U.S. health-care system. In addition to its insurance businesses, the company has built out a suite of health services and care-delivery capabilities intended to support value-based care initiatives and expand non-insurance offerings. Its scale and national footprint position Elevance to participate in a variety of care models and payment arrangements as the U.S. health-care landscape evolves.

Key Stats

• Today's Range: $367.50 to $373.73
• 50-Day Range: $280.80 to $376.39
• 52-Week Range: $273.71 to $424.24
• Volume: 682,591 shs
• Average Volume: 1.85 million shs
• Market Capitalization: $80.34 billion
• P/E Ratio: 15.73
• Dividend Yield: 1.86%
• Price Target: $384.58
• Consensus Rating: Moderate Buy

Elevance Health Stock Analysis - MarketRank™

Elevance Health scored higher than 89% of companies evaluated by MarketBeat, and ranked 59th out of 854 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Elevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 13 buy ratings, 10 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Elevance Health is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Elevance Health has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.32%

Earnings Growth

Earnings for Elevance Health are expected to grow by 8.32% in the coming year, from $26.79 to $29.02 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Elevance Health is 15.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.54.

Price to Earnings Ratio vs. Sector

The P/E ratio of Elevance Health is 15.78, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.12.

Price to Earnings Growth Ratio

Elevance Health has a PEG Ratio of 2.12. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Elevance Health has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.02% of the float of Elevance Health has been sold short.

Short Interest Ratio / Days to Cover

Elevance Health has a short interest ratio ("days to cover") of 2.96, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Elevance Health has recently increased by 11.27%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Elevance Health pays a meaningful dividend of 1.83%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Elevance Health has been increasing its dividend for 14 years.

Dividend Coverage

The dividend payout ratio of Elevance Health is 29.26%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Elevance Health will have a dividend payout ratio of 23.71% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: 1.03

News Sentiment

Elevance Health has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 26 news articles for Elevance Health this week, compared to 8 articles on an average week.

Search Interest

16 people have searched for ELV on MarketBeat in the last 30 days. This is an increase of 129% compared to the previous 30 days.

MarketBeat Follows

5 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Elevance Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,475.00 in company stock.

Percentage Held by Insiders

0.34% of the stock of Elevance Health is held by insiders.

Percentage Held by Institutions

89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ELV Stock Analysis - Frequently Asked Questions

How have ELV shares performed this year?

Elevance Health's stock was trading at $350.59 at the start of the year. Since then, ELV shares have increased by 6.0% and is now trading at $371.7940.

How were Elevance Health's earnings last quarter?

Elevance Health, Inc. (NYSE:ELV) released its earnings results on Wednesday, April, 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.74 by $1.84. The business's revenue for the quarter was up 1.5% compared to the same quarter last year.
Read the conference call transcript.

Does Elevance Health have any subsidiaries?

Elevance Health subsidiaries include these companies: Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and others.

Who are Elevance Health's major shareholders?

Top institutional investors of Elevance Health include SG Americas Securities LLC (0.36%), Sumitomo Mitsui Trust Group Inc. (0.28%), Hsbc Holdings PLC (0.24%) and Focused Investors LLC (0.23%). Insiders that own company stock include Gail Boudreaux, Felicia F Norwood, Charles Morgan Kendrick Jr, Robert L Dixon Jr, Ramiro G Peru, Susan D Devore and Ronald W Penczek.
View institutional ownership trends.

How do I buy shares of Elevance Health?

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Elevance Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Record date for 3/25 Dividend: 3/10/2026
• Ex-Dividend for 3/25 Dividend: 3/10/2026
• Dividend Payable: 3/25/2026
• Last Earnings: 4/22/2026
• Today: 5/05/2026
• AGM 2026: 5/13/2026
• Record date for 6/25 Dividend: 6/10/2026
• Ex-Dividend for 6/25 Dividend: 6/10/2026
• Dividend Payable: 6/25/2026
• Next Earnings (Estimated): 7/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:ELV
• CIK: 1156039
• Web: www.antheminc.com
• Phone: (800) 331-1476
• Fax: 317-488-6275
• Employees: 97,100
• Year Founded: 1944

Price Target and Rating

• Average Price Target for Elevance Health: $384.58
• High Price Target: $435.00
• Low Price Target: $331.00
• Potential Upside/Downside: +3.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 23 Analysts

Profitability

• EPS (Trailing Twelve Months): $23.51
• Trailing P/E Ratio: 15.74
• Forward P/E Ratio: 13.82
• P/E Growth: 2.12
• Net Income: $5.66 billion
• Net Margins: 2.62%
• Pretax Margin: 3.10%
• Return on Equity: 15.58%
• Return on Assets: 5.57%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 1.48
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $200.42 billion
• Price / Sales: 0.40
• Cash Flow: $37.33 per share
• Price / Cash Flow: 9.92
• Book Value: $198.10 per share
• Price / Book: 1.87

Miscellaneous

• Outstanding Shares: 217,162,000
• Free Float: 216,424,000
• Market Cap: $80.41 billion
• Optionable: Optionable
• Beta: 0.66